Drug DrugBank | All Description Patterns💬 Info on mouse-over
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY On map, Yellow: Drug target genes |
Disease ID |
| 1 | Caplacizumab | Anti-von willebrand factor nanobody, caplacizumab [6] Anti-von willebrand factor nanobody, caplacizumab; Anti-von willebrand factor nanobody, inn = caplacizumab; Caplacizumab; Caplacizumab (alx-0081); Caplacizumab (an anti-von willebrand factor nanobody alx-0081); Caplacizumab (an anti-von willebrand factor nanobody); | [1] D11160 D11160 💬 |
[1] VWF 💬 | Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |